Recombinant Human CXCL5/ENA-78 Protein 254-XB-025 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemRecombinant Human CXCL5/ENA-78 Protein
CompanyR&D Systems, a Bio-Techne Brand
Price $408.00Supplier Page View Company Product Page
Catalog Number254-XB-025
SpeciesHuman
Size25 ug
Source/Expression SystemE. coli-derived Recombinant Human CXCL5/ENA-78 Protein
Molecule NameCXCL5/ENA-78
NCBI Full Gene NameC-X-C motif chemokine ligand 5
NCBI Gene AliasesENA-78, SCYB5
FormatLyophilized from a 0.2 µm filtered solution in PBS containing BSA as carrier protein
Purity>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining
Molecular WeightObserved: 7 kDa, reducing conditions
Theoretical: 8.4 kDa
Conjugate/TagUnconjugated
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

(2) CXCL5 promotes mitomycin C resistance in non-muscle invasive bladder cancer by activating EMT and NF-κB pathwayBiochemical and biophysical research communicationsApril 15, 2018Wang C, Li A, Yang S, Qiao R, Zhu X, Zhang J.

(3) Complex cellular composition of solitary fibrous tumor of the prostateThe American journal of pathologyMarch 1, 2014Gharaee-Kermani M, Mehra R, Robinson DR, Wei JT, Macoska JA.

(4) CXCL5 stimulation of RANK ligand expression in Paget's disease of boneLaboratory investigation; a journal of technical methods and pathologyApril 1, 2013Sundaram K, Rao DS, Ries WL, Reddy SV.

(6) Staphylococcus aureus Staphopain A inhibits CXCR2-dependent neutrophil activation and chemotaxisThe EMBO journalAugust 29, 2012Laarman AJ, Mijnheer G, Mootz JM, van Rooijen WJ, Ruyken M, Malone CL, Heezius EC, Ward R, Milligan G, van Strijp JA, et al.

(7) Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitorsNatureJuly 26, 2012Wilson TR, Fridlyand J, Yan Y, Penuel E, Burton L, Chan E, Peng J, Lin E, Wang Y, Sosman J, et al.

(8) Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancerThe American journal of pathologyMarch 1, 2011Li A, King J, Moro A, Sugi MD, Dawson DW, Kaplan J, Li G, Lu X, Strieter RM, Burdick M, et al.

(9) Adipose tissue-derived stem cells secrete CXCL5 cytokine with chemoattractant and angiogenic propertiesBiochemical and biophysical research communicationsNovember 19, 2010Zhang H, Ning H, Banie L, Wang G, Lin G, Lue TF, Lin CS.

Recombinant Human CXCL5/ENA-78 Protein from R&D Systems, a Bio-Techne Brand